Healthcare
Live Price
Offline$65.79
+4.71% today
1Y Change
-13.02%
Window
Jun 23, 2025 โ Jun 11, 2026
Coverage: 244 bars ยท Jun 23, 2025 โ Jun 11, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
U.S. Physical Therapy, Inc. (USPH) is a Healthcare stock with a market cap of $1.09B and listed on NYSE. The stock last traded around $65.79 and down 13.0% across the available one-year price window (Jun 23, 2025 โ Jun 11, 2026). Baseline metrics include revenue growth of +16.3%, EPS growth of -22.8%, a dividend yield of 2.5%. What stands out right now is revenue +16.3%, EPS -22.8%, free cash flow -7.2% with operating margin 13.4% and ROIC 6.1%. The dividend matters to the case here, with a current yield around 2.5%. Valuation already assumes a fairly strong business story at P/E 70.7 and price/sales 1.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines USPH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+16.3% vs +7.6% peer median
Operating Margin
Below sector median
+13.4% vs +19.4% peer median
P/E
Above sector median
70.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +16.3% and EPS is at -22.8%, with operating margin around 13.4%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 2.5%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -11.0% over the next 5 trading days and finished higher after 1 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | -19.9% | -18.3% | -16.1% |
2026 Feb 25, 2026 | +0.0% | -2.9% | +3.0% | -8.2% |
2025 Nov 5, 2025 | -1.5% | -11.9% | -17.6% | -13.3% |
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
USPH
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
USPH Max Drawdown
-36.67%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for USPH and SPY.

Company Overview
U.S. Physical Therapy, Inc.
New York Stock Exchange
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.